Cell biology assessment of glucokinase mutations V62M and G72R in pancreatic beta-cells: evidence for cellular instability of catalytic activity.

Cell biology assessment of glucokinase mutations V62M and G72R in pancreatic beta-cells: evidence for cellular instability of catalytic activity.

Mutations in the glucokinase (GK) gene cause defects in blood glucose homeostasis. In some cases (V62M and G72R), the phenotype cannot be explained by altered enzyme kinetics or protein instability. We used transient and stable expression of green fluorescent protein (GFP) GK chimaeras in MIN6 beta-...

ver descrição completa

Detalhes bibliográficos
Principais autores:	Arden, C, Trainer, A, de la Iglesia, N, Scougall, K, Gloyn, A, Lange, A, Shaw, J, Matschinsky, F, Agius, L
Formato:	Journal article
Idioma:	English
Publicado em:	2007

Registros relacionados

Catalytic instability of the glucokinase MODY-2 mutants V62M and G72R in pancreatic beta cells
por: Arden, C, et al.
Publicado em: (2006)

Glucokinase (GCK) and other susceptibility genes for beta-cell dysfunction: the candidate approach.
por: Gloyn, A, et al.
Publicado em: (2008)

Insights into biochemical and genetical basis of glucokinase activation from naturally occuring hypoglycaemia mutations
por: Gloyn, A, et al.
Publicado em: (2003)

Insights into the structure and regulation of glucokinase from a novel mutation (V62M), which causes maturity-onset diabetes of the young.
por: Gloyn, A, et al.
Publicado em: (2005)

Insights into the biochemical and genetic basis of glucokinase activation from naturally occurring hypoglycemia mutations.
por: Gloyn, A, et al.
Publicado em: (2003)

Mutations in the genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) in diabetes mellitus and hyperinsulinism.
por: Gloyn, A, et al.
Publicado em: (2006)

Identification of a novel beta cell glucokinase (GCK) promoter mutation (-71 G > C) which reduces promoter activity
por: Gasperikova, D, et al.
Publicado em: (2008)

A panel of diverse assays to interrogate the interaction between glucokinase and glucokinase regulatory protein, two vital proteins in human disease
por: Rees, MG, et al.
Publicado em: (2014)

NGF effects promote the maturation of rat pancreatic beta cells by regulating GLUT2 levels and distribution, and glucokinase activity.
por: Jazmín Samario-Román, et al.
Publicado em: (2024-01-01)

Glucokinase (GCK) mutations in hyper- and hypoglycemia: maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy.
por: Gloyn, A
Publicado em: (2003)

Naturally occurring glucokinase mutations are associated with defects in posttranslational S-nitrosylation.
por: Ding, S, et al.
Publicado em: (2010)

Small molecular glucokinase activators: has another new anti-diabetic therapeutic lost favour?
por: Rees, MG, et al.
Publicado em: (2013)

Small molecular glucokinase activators: Has another new anti-diabetic therapeutic lost favour?
por: Rees, MG, et al.
Publicado em: (2014)

Functional characterisation of the glucokinase regulatory protein gene variant P446L shows diminished regulation by fructose-6 phosphate resulting in increased glucokinase activity
por: Beer, N, et al.
Publicado em: (2009)

α-cell glucokinase suppresses glucose-regulated glucagon secretion
por: Basco, D, et al.
Publicado em: (2018)

Investigating novel mutational mechanisms for glucokinase mutations with near normal or paradoxical kinetics
por: Tribble, N, et al.
Publicado em: (2009)

Complete glucokinase deficiency is not a common cause of permanent neonatal diabetes.
por: Gloyn, A, et al.
Publicado em: (2002)

A panel of diverse assays to interrogate the interaction between glucokinase and glucokinase regulatory protein, two vital proteins in human disease.
por: Matthew G Rees, et al.
Publicado em: (2014-01-01)

Association of glucokinase, glucokinase regulator, glucose-6-phosphatase catalytic subunit 2 and melatonin receptor 1b genes polymorphisms with type 2 diabetic subjects
por: Ansari, Neda
Publicado em: (2020)

Meaux (Seine-et-Marne). 62-72, rue Saint-Faron
por: David Couturier
Publicado em: (2004-10-01)

Update of mutations in the genes encoding the pancreatic beta-cell K(ATP) channel subunits Kir6.2 (KCNJ11) and sulfonylurea receptor 1 (ABCC8) in diabetes mellitus and hyperinsulinism.
por: Flanagan, SE, et al.
Publicado em: (2009)

The role of genetic variation in glucokinase and glucokinase regulatory protein in diabetes and related traits
por: Beer, N, et al.
Publicado em: (2011)

Gene duplications resulting in over expression of glucokinase are not a common cause of hypoglycaemia of infancy in humans.
por: van de Bunt, M, et al.
Publicado em: (2008)

Persistent hyperinsulinemic hypoglycemia in a 7 yr old girl due to a novel activating glucokinase mutation
por: Lahr, G, et al.
Publicado em: (2007)

Association studies of variants in promoter and coding regions of beta-cell ATP-sensitive K-channel genes SUR1 and Kir6.2 with Type 2 diabetes mellitus (UKPDS 53).
por: Gloyn, A, et al.
Publicado em: (2001)

Identification and functional characterisation of novel inactivating glucokinase mutations causing GCK-MODY in Slovakia
por: Valentinova, L, et al.
Publicado em: (2011)

Screening for mutations in the Kir6.2 subunit of the beta-cell K-ATP channel
por: Sakura, H, et al.
Publicado em: (1996)

Prevalence of glucokinase (GCK) mutations in people with elevated fasting glucose levels: implications for clinical trials
por: Gloyn, A, et al.
Publicado em: (2007)

Familial persistent hyperinsulinaemic hypoglycaemia of infancy due to a novel glucokinase (GCK) activating mutation G68V
por: Gloyn, A, et al.
Publicado em: (2006)

Kir6.2-dependent high-affinity repaglinide binding to beta-cell K(ATP) channels.
por: Hansen, A, et al.
Publicado em: (2005)

Permanent neonatal diabetes due to paternal germline mosaicism for an activating mutation of the KCNJ11 Gene encoding the Kir6.2 subunit of the beta-cell potassium adenosine triphosphate channel.
por: Gloyn, A, et al.
Publicado em: (2004)

Conformational transition pathway of R308K mutant glucokinase in the presence of the glucokinase activator YNKGKA4
por: Nanda Kumar Yellapu, et al.
Publicado em: (2018-08-01)

Identification of 21 novel glucokinase (GCK) mutations in UK and European Caucasians with maturity-onset diabetes of the young (MODY).
por: Thomson, K, et al.
Publicado em: (2003)

Identification and functional characterisation of novel glucokinase mutations causing maturity-onset diabetes of the young in Slovakia.
por: Valentinova, L, et al.
Publicado em: (2012)

Insights into glucokinase regulatory protein regulation from the cellular and kinetic characterisation of rare coding variants
por: Rees, MG, et al.
Publicado em: (2010)

Naturally occurring glucokinase mutations at the same amino acid residue cause opposite clinical phenotypes of hypo- and hyperglycaemia
por: Beer, N, et al.
Publicado em: (2010)

Expression of an activating mutation in the gene encoding the KATP channel subunit Kir6.2 in mouse pancreatic beta cells recapitulates neonatal diabetes.
por: Girard, C, et al.
Publicado em: (2009)

Genome-edited human stem cell-derived beta cells: a powerful tool for drilling down on type 2 diabetes GWAS biology
por: Beer, N, et al.
Publicado em: (2016)

Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia.
por: Osbak, K, et al.
Publicado em: (2009)

Permanent neonatal diabetes mellitus caused by a novel homozygous (T168A) glucokinase (GCK) mutation: initial response to oral sulphonylurea therapy.
por: Turkkahraman, D, et al.
Publicado em: (2008)